Skip to main content
. 2020 Nov 13;10(4):226. doi: 10.3390/jpm10040226

Table 2.

Clinicopathological characteristics in the patients.

All Patients MAC NMAC p-Values 1
n = 433 (%) n = 54 (%) n = 379 (%)
Sex 0.785
Male 266 30 (56) 248 (58)
Female 185 24 (44) 161 (42)
Age (years) 0.267
≤69 202 29 (54) 173 (46)
>69 231 25 (46) 206 (54)
TNM stage 0.015
I 129 7 (13) 122 (32)
IIA 110 10 (19) 100 (26)
IIB 10 2 (4) 8 (2)
IIIA 17 2 (4) 15 (4)
IIIB 57 11 (20) 46 (12)
IIIC 56 11 (20) 45 (12)
IV 54 11 (20) 43 (11)
T-stage 0.008
T1 49 0 49 (13)
T2 113 11 (20) 102 (27)
T3 230 35 (65) 195 (52)
T4 38 8 (15) 30 (8)
Unknown 3 0 3 (1)
N-stage 0.013
N0 244 21 (41) 223 (63)
N1 86 15 (29) 71 (20)
N2 77 15 (29) 62 (17)
Unknown 26 3 (6) 23 (6)
Vascular invasion 0.676
Yes 87 12 (22) 75 (20)
No 346 42 (78) 304 (80)
Perineural growth 0.340
Yes 58 5 (9) 53 (14)
No 375 49 (91) 326 (86)
Differentiation <0.001
Well 42 1 (2) 41 (11)
Moderately 287 19 (35) 251 (66)
Poorly 132 34 (63) 87 (23)

MAC = mucinous adenocarcinoma, NMAC = non-mucinous adenocarcinoma. 1 p-values calculated by Chi-square test and compare MAC patients and NMAC patients.